VAERS Explorer
Back to explore

Report #2832120

Received Mar 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
72 yrs
State
—
Recovered
Unknown
Vaccinated
Mar 10, 2025
Onset
Mar 10, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK579F4—

Symptoms (1)

Expired product administered

Symptom narrative

patient received an expired dose of Arexvy; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 72-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 579F4, expiry date 23-JAN-2025) for prophylaxis. On 10-MAR-2025, the patient received Arexvy. On 10-MAR-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: patient received an expired dose of Arexvy). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 10-MAR-2025 Pharmacist reported a patient received an expired dose of AREXVY on 10th March 2025, which led to Expired vaccine used.